IMF_logo_RGB.png
International Myeloma Foundation (IMF) to Hold In-Person 2023 Patient and Family Seminar in Los Angeles in August
13 juil. 2023 08h45 HE | International Myeloma Foundation
LOS ANGELES, July 13, 2023 (GLOBE NEWSWIRE) -- The International Myeloma Foundation (IMF) today announced that a 2023 IMF Patient and Family Seminar (PFS) will take place in-person from August 18-19...
IMF_logo_RGB.png
The International Myeloma Foundation’s Nurse Leadership Board Launches Myeloma University
06 juil. 2023 08h45 HE | International Myeloma Foundation
LOS ANGELES, July 06, 2023 (GLOBE NEWSWIRE) -- The International Myeloma Foundation’s (IMF) Nurse Leadership Board (NLB) today announced the launch of Myeloma University—a FREE online educational...
Harpoon_logo (002).jpg
Harpoon Therapeutics Announces Completion of Planned Patient Enrollment in Phase 1 Study of HPN217 in Relapsed/Refractory Multiple Myeloma
27 juin 2023 07h30 HE | Harpoon Therapeutics
SOUTH SAN FRANCISCO, Calif., June 27, 2023 (GLOBE NEWSWIRE) -- Harpoon Therapeutics, Inc. (Nasdaq: HARP), a clinical-stage immuno-oncology company developing novel T cell engagers, today announced...
IMF_logo_RGB.png
The International Myeloma Foundation (IMF) Honors 2023 Research Achievement Awardees, Dr. Maria-Victoria Mateos and Dr. Thomas Martin
01 juin 2023 08h45 HE | International Myeloma Foundation
LOS ANGELES, June 01, 2023 (GLOBE NEWSWIRE) -- The International Myeloma Foundation (IMF) is proud to announce the recipients of this year’s Robert A. Kyle Achievement Award and Brian G.M. Durie...
IMF_logo_RGB.png
International Myeloma Foundation to Host 2023 Global Myeloma Action Network (GMAN) Summit in Frankfurt 
25 mai 2023 08h45 HE | International Myeloma Foundation
LOS ANGELES, May 25, 2023 (GLOBE NEWSWIRE) -- Founded in 2013 by the International Myeloma Foundation (IMF), the Global Myeloma Action Network (GMAN) will hold its Annual Summit in Frankfurt...
IMF_logo_RGB.png
‘Crazy Guy on a Bike’ Andy Sninsky: Over 10 Years of Pedaling for Multiple Myeloma and Bringing Hope
18 mai 2023 05h45 HE | International Myeloma Foundation
LOS ANGELES, May 18, 2023 (GLOBE NEWSWIRE) -- Diagnosed in 2008 at age 59 with multiple myeloma, Andy Sninsky continues to be a formidable inertia in motion and a perpetual source of inspiration for...
IMF_logo_RGB.png
The Annual Czerkies Memorial Golf Outing: 15 Years of Helping the International Myeloma Foundation (IMF) Find a Cure for Multiple Myeloma
16 mai 2023 05h45 HE | International Myeloma Foundation
A Media Snippet accompanying this announcement is available by clicking on the image or link below: LOS ANGELES, May 16, 2023 (GLOBE NEWSWIRE) -- Now on its 15th year, the Annual Czerkies...
IMF_logo_RGB.png
The International Myeloma Foundation (IMF) Launches Medical Student Scholars for Health Equity in Myeloma Mentoring Program
20 avr. 2023 08h45 HE | International Myeloma Foundation
STUDIO CITY, Calif., April 20, 2023 (GLOBE NEWSWIRE) -- The International Myeloma Foundation (IMF) has partnered with the W. Montague Cobb/NMA Health Institute’s Cobb Scholars Program to develop a...
Harpoon_logo (002).jpg
Harpoon Therapeutics to Participate in the Canaccord Horizons in Oncology Conference
10 avr. 2023 16h05 HE | Harpoon Therapeutics
SOUTH SAN FRANCISCO, Calif., April 10, 2023 (GLOBE NEWSWIRE) -- Harpoon Therapeutics, Inc. (NASDAQ: HARP), a clinical-stage immuno-oncology company developing novel T cell engagers, today announced...
IMF_logo_RGB.png
One Community, One Question: What Is Your #MYelomaSTORY?
06 avr. 2023 08h45 HE | International Myeloma Foundation
STUDIO CITY, Calif., April 06, 2023 (GLOBE NEWSWIRE) -- At the conclusion of this year’s Myeloma Action Month (MAM), the International Myeloma Foundation (IMF) was truly grateful for everyone’s...